Elham Mohebbi
1, Ali Akbar Haghdoost
2, Alireza Noroozi
3,4, Hossein Molavi Vardanjani
5, Ahmad Hajebi
6, Roya Nikbakht
2, Maryam Mehrabi
7,8, Akram Jabbarinejad Kermani
9, Mahshid Salemianpour
2, Mohammad Reza Baneshi
2*1 HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
2 Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
3 School of Advanced Technologies in Medicine (SATiM), Tehran University of Medical Sciences (TUMS), Tehran, Iran.
4 Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences (TUMS), Tehran, Iran.
5 MPH Department, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.
6 Research Center for Addiction & Risky Behavior (ReCARB), Psychiatric Department, Iran University of Medical Sciences, Tehran, Iran.
7 Department of Sociology, Faculty of Social Sciences and Economics, Alzahra University, Tehran, Iran.
8 Department of Mental, Social Health and Drug Use, Ministry of Health, Tehran, Iran.
9 Social Determinants of Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Abstract
Background: Providing population-based data on awareness, attitude and practice of drug and stimulant use
has policy implications. A national study was conducted among Iranian general population to explore life time
prevalence, awareness and attitudes toward opioids and stimulant use.
Methods: We recruited subjects from 5 provinces with heterogenic pattern of drug use. Participants were
selected using stratified multistage cluster sampling. Data were collected using a validated self-administered
questionnaire. Logistic regression model was applied to identify the variables that are associated with drug and
stimulant use.
Results: In total 2065 respondents including 1155 men (33.96 ± 10.40 years old) and 910 women (35.45 ±
12.21 years old) were recruited. Two-third of respondents had good awareness about adverse effects of opioid
use. Corresponding figure in terms of stimulants was 81.4%. Almost 95% of participants reported a negative
attitude towards either opioid or stimulant use. The lifetime prevalence of opioid use and stimulant use were
12.9% (men: 21.5%, women: 4.0%) and 7.3% (men: 9.6%, women: 4.9%), respectively. Gender (adjusted odds
ratio [AOR]M/W=6.92; 95% CI: 2.92, 16.42), education (AORundergraduate/diploma or less =0.49; 95% CI: 0.26, 0.90), and
marital status (AORothers/single=2.13; 95% CI: 1.36, 3.33) were significantly related with opioid use. With respect
to stimulant use, age was negatively associated with the outcome (AOR60+/20-29 years = 0.08: 95% CI; 0.01, 0.98) and
men were 2 times more likely than women to use stimulants (ORM/W=2.15: 95% CI: 0.83, 5.56). In addition,
marital status (AOROthers/singles = 3.45; 95% CI: 1.09, 10.93), and awareness (AORWeak and moderate/good =0.40; 95% CI:
0.25, 0.61) were independently correlated with stimulants use.
Conclusion: While the attitude of Iranian adults toward opioid and stimulant use was negative, their awareness
was not that adequate to prevent the drug use. Men and those with lower socio-economic status (SES) should be
the focus of health promotion programs regarding opioid use. However, regarding stimulants use, promotion
programs should target younger age groups and those with higher SES status